Kareem Ebeid

487 total citations
21 papers, 347 citations indexed

About

Kareem Ebeid is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kareem Ebeid has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Kareem Ebeid's work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers) and Immunotherapy and Immune Responses (3 papers). Kareem Ebeid is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers) and Immunotherapy and Immune Responses (3 papers). Kareem Ebeid collaborates with scholars based in United States, Egypt and Thailand. Kareem Ebeid's co-authors include Aliasger K. Salem, Sean M. Geary, Emad I. Wafa, Youssef W. Naguib, Xiangbing Meng, Amaraporn Wongrakpanich, Angie S. Morris, Kristina W. Thiel, Aml I. Mekkawy and Kimberly K. Leslie and has published in prestigious journals such as ACS Nano, Nature Nanotechnology and Biomaterials.

In The Last Decade

Kareem Ebeid

19 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kareem Ebeid United States 12 165 74 73 51 46 21 347
Mengdi Song China 7 176 1.1× 79 1.1× 100 1.4× 23 0.5× 35 0.8× 11 364
Xiuhua Wu China 10 230 1.4× 52 0.7× 39 0.5× 46 0.9× 76 1.7× 11 442
Qingqing Huang China 12 162 1.0× 83 1.1× 101 1.4× 36 0.7× 20 0.4× 32 347
Yun‐Chi Lu Taiwan 11 203 1.2× 82 1.1× 62 0.8× 34 0.7× 100 2.2× 16 356
Emad I. Wafa United States 13 171 1.0× 94 1.3× 116 1.6× 65 1.3× 87 1.9× 19 404
Raluca Munteanu Romania 10 138 0.8× 52 0.7× 61 0.8× 18 0.4× 65 1.4× 19 371
Amanda E. Brinker United States 11 207 1.3× 43 0.6× 39 0.5× 30 0.6× 77 1.7× 15 351
Sishir K. Kamalapuram Australia 8 191 1.2× 41 0.6× 41 0.6× 42 0.8× 67 1.5× 10 333
Sandeep Urandur India 13 197 1.2× 156 2.1× 151 2.1× 47 0.9× 71 1.5× 16 438

Countries citing papers authored by Kareem Ebeid

Since Specialization
Citations

This map shows the geographic impact of Kareem Ebeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kareem Ebeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kareem Ebeid more than expected).

Fields of papers citing papers by Kareem Ebeid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kareem Ebeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kareem Ebeid. The network helps show where Kareem Ebeid may publish in the future.

Co-authorship network of co-authors of Kareem Ebeid

This figure shows the co-authorship network connecting the top 25 collaborators of Kareem Ebeid. A scholar is included among the top collaborators of Kareem Ebeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kareem Ebeid. Kareem Ebeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jana, Deblin, Zhiyuan Han, Xiao Huang, et al.. (2024). Enhanced Prostate-specific Membrane Antigen Targeting by Precision Control of DNA Scaffolded Nanoparticle Ligand Presentation. ACS Nano. 18(26). 16674–16683. 9 indexed citations
2.
Naguib, Youssef W., Emad I. Wafa, Sanjib Saha, et al.. (2023). A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials. 296. 122093–122093. 12 indexed citations
3.
Naguib, Youssef W., Emad I. Wafa, Sanjib Saha, et al.. (2023). Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer. Small. 20(41). e2302931–e2302931. 11 indexed citations
4.
Wafa, Emad I., et al.. (2022). Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine. Science Advances. 8(29). eabk3150–eabk3150. 27 indexed citations
5.
Ebeid, Kareem, Sean M. Geary, & Aliasger K. Salem. (2022). Preparation and Characterization of a Liver Targeted, Poly(amidoamine) Based, Gene Delivery System. Methods in molecular biology. 2455. 319–332. 5 indexed citations
6.
El‐Hafeez, Amer Ali Abd, Kareem Ebeid, Aml I. Mekkawy, et al.. (2022). New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1346–1363. 41 indexed citations
7.
Ebeid, Kareem, Juliana C. Quarterman, Youssef W. Naguib, et al.. (2022). Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model. Bioconjugate Chemistry. 33(11). 1957–1972. 24 indexed citations
8.
9.
Wafa, Emad I., Kareem Ebeid, Sean M. Geary, et al.. (2021). Thiophene Derivative‐Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly. Advanced Therapeutics. 4(7). 12 indexed citations
10.
Mekkawy, Aml I., Youssef W. Naguib, Emad I. Wafa, et al.. (2021). Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice. International Journal of Pharmaceutics. 606. 120876–120876. 18 indexed citations
11.
Mekkawy, Aml I., Juliana C. Quarterman, Youssef W. Naguib, et al.. (2021). The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles. Drug Delivery and Translational Research. 12(7). 1684–1696. 10 indexed citations
12.
Naguib, Youssef W., Sanjib Saha, Jessica M. Skeie, et al.. (2021). Solubilized ubiquinol for preserving corneal function. Biomaterials. 275. 120842–120842. 19 indexed citations
13.
Lemke, Caitlin D., Sue Blackwell, Aaron Bossler, et al.. (2021). Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod. Vaccines. 9(9). 982–982. 3 indexed citations
14.
15.
Amaral-Machado, Lucas, Éverton do Nascimento Alencar, Hugo Alexandre Oliveira Rocha, et al.. (2019). Bullfrog oil (Rana catesbeiana Shaw) induces apoptosis, in A2058 human melanoma cells by mitochondrial dysfunction triggered by oxidative stress. Biomedicine & Pharmacotherapy. 117. 109103–109103. 12 indexed citations
16.
Bi, Jianling, Shujie Yang, Yuping Zhang, et al.. (2019). MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Gynecologic Oncology. 155(2). 349–358. 17 indexed citations
17.
Ebeid, Kareem, et al.. (2019). A Large Mitral Valve Vegetation Not Visualized on Transthoracic Echocardiography: A Case Report. American Journal of Case Reports. 20. 1422–1426. 1 indexed citations
18.
Ebeid, Kareem, Xiangbing Meng, Kristina W. Thiel, et al.. (2017). Synthetically lethal nanoparticles for treatment of endometrial cancer. Nature Nanotechnology. 13(1). 72–81. 63 indexed citations
19.
Morris, Angie S., Sara C. Sebag, J.D. Paschke, et al.. (2017). Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma. Molecular Pharmaceutics. 14(6). 2166–2175. 18 indexed citations
20.
Ebeid, Kareem, et al.. (2016). HPLC-UV method for simultaneous determination of MK-1775 and AZD-7762 in both acetonitrile-aqueous solution and mouse plasma. Journal of Chromatography B. 1044-1045. 70–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengdi Song Breakdown of academic impact, for papers by Xiuhua Wu Breakdown of academic impact, for papers by Qingqing Huang Breakdown of academic impact, for papers by Yun‐Chi Lu Breakdown of academic impact, for papers by Emad I. Wafa Breakdown of academic impact, for papers by Raluca Munteanu Breakdown of academic impact, for papers by Amanda E. Brinker Breakdown of academic impact, for papers by Sishir K. Kamalapuram Breakdown of academic impact, for papers by Sandeep Urandur
Rankless by CCL
2026